Adrenal disease

Biochemical Diagnosis of Phaeochromocytoma and Paraganglioma in Children and Adolescents: A Retrospective Cohort Study

Clin Endocrinol (Oxf)Published Retrospective cohort study

Authors' conclusion

Plasma free and 24-h urinary fractionated metanephrines are both reliable screening tests for PPGL in children and adolescents. The plasma panel may be useful for early detection of noradrenergic PPGL relevant for children tested within surveillance programs due to hereditary risk of noradrenergic tumours.

Study context

Population
Paediatric patients aged 5 to 18 years tested for PPGL; 64 with and 74 without PPGL
Participants
138 vs 89
Exposure
Plasma free metanephrines vs 24-h urinary fractionated metanephrines
  • Plasma metanephrinesn = 138
  • Urinary metanephrinesn = 89
Outcome
Diagnostic reliability (sensitivity, specificity) of plasma free and 24-h urinary fractionated metanephrines for PPGL screening

Main finding

As reported in the abstract

Diagnostic performance for PPGL
GroupSensitivitySpecificity
Plasma metanephrines92%96%
Urinary metanephrines92%91%

Sensitivity

Plasma metanephrines92%
Urinary metanephrines92%

Specificity

Plasma metanephrines96%
Urinary metanephrines91%

Observational data: associations, not effects.

Further findings

OutcomePlasma metanephrinesUrinary metanephrinesP value
Fold increase of normetanephrine above upper cut-off in children with PPGLLarger fold increase with plasma9.5-fold7.1-foldP < 0.001

Intra-individual temporal measurements

Subsequent increases of plasma normetanephrine may be associated with early-stage development of a noradrenergic PPGL
  • Sub-analysis

Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.

Original publication

Biochemical Diagnosis of Phaeochromocytoma and Paraganglioma in Children and Adolescents: A Retrospective Cohort Study. Clin Endocrinol (Oxf). Published 21 August 2025. doi:10.1111/cen.70025

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.